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MaBACKGROUND Familial restrictive cardiomyopathy (FRCM) has a poor prognosis due to diastolic dysfunction and
restrictive physiology (RP). Myocardial stiffness, with or without ﬁbrosis, underlie RP, but the mechanism(s) of restrictive
remodeling is unclear. Myopalladin (MYPN) is a messenger molecule that links structural and gene regulatory molecules
via translocation from the Z-disk and I-bands to the nucleus in cardiomyocytes. Expression of N-terminal MYPN peptide
results in severe disruption of the sarcomere.
OBJECTIVES The aim was to study a nonsense MYPN-Q529X mutation previously identiﬁed in the FRCM family in
an animal model to explore the molecular and pathogenic mechanisms of FRCM.
METHODS Functional (echocardiography, cardiac magnetic resonance [CMR] imaging, electrocardiography), morpho-
histological, gene expression, and molecular studies were performed in knock-in heterozygote (MypnWT/Q526X) and
homozygote mice harboring the human MYPN-Q529X mutation.
RESULTS Echocardiographic and CMR imaging signs of diastolic dysfunction with preserved systolic function
were identiﬁed in 12-week-old MypnWT/Q526X mice. Histology revealed interstitial and perivascular ﬁbrosis without
overt hypertrophic remodeling. Truncated MypnQ526X protein was found to translocate to the nucleus. Levels of total
and nuclear cardiac ankyrin repeat protein (Carp/Ankrd1) and phosphorylation of mitogen-activated protein kinase/
extracellular signal–regulated kinase 1/2 (Erk1/2), Erk1/2, Smad2, and Akt were reduced. Up-regulation was evident
for muscle LIM protein (Mlp), desmin, and heart failure (natriuretic peptide A [Nppa], Nppb, and myosin heavy
chain 6) and ﬁbrosis (transforming growth factor beta 1, alpha–smooth muscle actin, osteopontin, and periostin)
markers.
CONCLUSIONS Heterozygote MypnWT/Q526X knock-in mice develop RCM due to persistence of mutant MypnQ526X
protein in the nucleus. Down-regulation of Carp and up-regulation of Mlp and desmin appear to augment ﬁbrotic
restrictive remodeling, and reduced Erk1/2 levels blunt a hypertrophic response in MypnWT/Q526X hearts.
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regulated kinase
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2766R estrictive cardiomyopathy (RCM)accounts for approximately 5% ofdiagnosed cardiomyopathies and is
characterized by diastolic dysfunction and
restrictive physiology (RP), whereas systolic
function typically remains normal or near
normal (1). The volume and wall thickness
of the ventricles are usually normal or
small, whereas atrial or biatrial enlargement
occurs due to impaired ventricular ﬁlling
during diastole (2). Particularly in children,
RCM has the poorest prognosis among all
types of heart muscle diseases, with 2- and
5-year mortality rates of 50% and 70%,
respectively, and the highest rate of sudden
cardiac death (SCD) (3). Survivors ultimately
develop heart failure (HF) due to RP, as well
as pulmonary hypertension; however, the
mechanistic basis of RP with diastolicdysfunction, myocardial ﬁbrosis, and cardiac stiff-
ness is unclear.SEE PAGE 2777A history of familial RCM (FRCM) is reported in
approximately 30% of RCM cases, with autosomal
dominant inheritance most commonly noted (4).
Several genes, typically encoding proteins of the
sarcomere, Z-disk, cytoskeleton, or intermediate
ﬁlament network, have been associated with auto-
somal dominant FRCM (4). The myopalladin (MYPN)
gene, which is located at chromosome 10q21.3, en-
codes a 145-kDa protein that participates in linking
regulatory molecules involved in sarcomeric I-band
and Z-disk assembly and muscle gene expression
(5). The N-terminal MYPN interacts with cardiac
ankyrin repeat protein (CARP/ANKRD1), a tran-
scriptional coinhibitor of genes involved in the
development of HF and hypertrophy (6). MYPN has
dual localization, sarcoplasm and nucleus, similar to
that seen with CARP (5). At the Z-disk, MYPN
interacts with alpha-actinin and with the SRC
homology 3 domain of nebulette (7). Mutations in
the MYPN gene cause diverse phenotypes in
humans, including dilated cardiomyopathy, hyper-
trophic cardiomyopathy, and RCM (8,9). We previ-
ously reported a nonsense autosomal dominant
mutation (MYPN-Q529X) that resulted in FRCM in
siblings via disturbed myoﬁbrillogenesis and sarco-
meric Z-disk disruption (9).
In this study, knock-in mice carrying a heterozy-
gous and homozygous Mypn-Q526X mutation in
exon 10 of the murine Mypn gene, homologous to
the human MYPN-Q529X mutation, were analyzedto determine the pathophysiology and molecular
mechanism(s) of FRCM.
METHODS
GENERATION OF KNOCK-IN MICE. The study con-
formed to the protocols approved by the Institutional
Animal Care and Use Committee at Cincinnati Chil-
dren’s Hospital Medical Center. To generate a murine
Mypn-Q526X mutation, we targeted exon 10 in the
Mypn gene (Online Figure 1A) using a homologous
recombination method as described previously (10)
and detailed in the Online Appendix.
EVALUATION OF HEART FUNCTION IN MICE. Serial
echocardiography and electrocardiography were per-
formed in mice at 6 and 12 weeks of age (12 animals/
group). Cardiac magnetic resonance imaging was
performed in 12-week-old animals when mice showed
a markedly increased early (E) and late (A) diastolic
velocities (E/A) ratio, signs of “restrictive ﬁlling,” or
diastolic dysfunction by echocardiography. See the
Online Appendix for experimental details.
HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY, QUANTITATIVE
REAL-TIME POLYMERASE CHAIN REACTION, AND ELECTRON
MICROSCOPY. Histopathology, including hematoxylin
and eosin, Masson trichrome, immunohistochemical,
transcriptional, and terminal deoxynucleotidyl tran-
sferase dUTP nick end-labeling (TUNEL) analysis,
was performed to assess structural, ﬁbrotic, hyper-
trophic, and/or apoptotic remodeling in the heart.
Transmission electron microscopy was performed
on glutaraldehyde-perfused hearts as previously
described (11). After isolation of total RNA from ven-
tricular tissues, quantitative real-time polymerase
chain reaction (PCR) was performed as described in
the Online Appendix. Six 12-week-old animals per
group were used. See experimental details in the
Online Appendix.
PROTEIN EXPRESSION, PULL-DOWN, AND WESTERN
BLOTTING. Human embryonic kidney (HEK293) cells
were transfected with different chimeras of MYPN–
green ﬂuorescent protein (GFP) and CARP-V5 com-
plementary DNA (cDNA) to evaluate MYPN and CARP
interactions using immunoprecipitation and coim-
munoprecipitation. Cellular fractionation was per-
formed using the NE-PER kit (Pierce, Rockford,
Illinois). Western blotting was used for protein
evaluation, and levels of proteins were quantiﬁed
in relative density units using ImageJ software as
described in the Online Appendix.
STATISTICAL ANALYSIS. Statistical analysis, re-
ported as mean  standard error of the mean, was
J A C C V O L . 6 4 , N O . 2 5 , 2 0 1 4 Huby et al.
D E C E M B E R 3 0 , 2 0 1 4 : 2 7 6 5 – 7 6 Z-Disk in Restrictive Cardiomyopathy
2767performed with the Student t test or 1-way analysis
of variance using GraphPad5 software (GraphPad
Software, Inc., La Jolla, California). A probability
value of p # 0.05 was considered signiﬁcant.
RESULTS
MANIFESTATION OF DIASTOLIC DYSFUNCTION. Given
that persistence of the 65-kDa MypnQ526X peptide
in vivo may potentially cause a “poison peptide”
effect, levels of the Mypn protein were conﬁrmed
by Western blotting; the MypnWT/Q526X line 3 with
the highest 65-kDa MypnQ526X protein expression
was selected for further breeding (Online Figure 1B).
Heterozygous and homozygous recombination of the
Mypn-Q526X mutation was conﬁrmed by sequencing
of Mypn exon 10 in genomic DNA obtained from
mouse tails (Online Figure 1C). We veriﬁed Mypn
mRNA transcription levels in the heart, skeletal
muscle, liver, and kidneys by reverse transcriptase
PCR. As expected, homozygotes had impaired Mypn
mRNA transcription in heart and skeletal muscle
compared with wild-type (WT) and heterozygote
littermates (Online Figures 1D and 1E). Thus, homo-
zygous MypnQ526X mice were also generated as a
model of Mypn gene ablation.
Both MypnWT/Q526X and MypnQ526X mice were born
and grew normally, with no skeletal myopathy
observed up to 12 weeks of age. At 6 weeks, increased
E/A ratios, features of RP in humans (12), were
detected in MypnWT/Q526X mice compared with WT
and homozygotes. The same cohort of mice under-
went a serial echocardiography at 12 weeks of age,
and the E/A ratio increased signiﬁcantly (Figure 1A).
Although systolic function and chamber dimensions
were preserved, MypnWT/Q526X mice showed signs of
impaired diastolic ﬁlling of the left ventricle (LV),
including decreased end-diastolic volume (LVEDV)
and internal dimensions compared with WT and
homozygotes (Online Table 1).
Further, cardiac magnetic resonance imaging was
used in the same cohort of 12-week-old mice to pre-
cisely evaluate cardiac anatomy and diastolic func-
tion. No signiﬁcant differences between groups were
found in circumferential strain, strain rate, torsion, or
torsion rate (data not shown). The left atrial cross-
sectional area of MypnWT/Q526X mice (3.8  0.5 mm2)
was larger compared with that of WT mice (3.5 
0.6 mm2) and homozygotes (3.0  0.3 mm2; p ¼ 0.02),
as measured in the 4-chamber view (Figure 1B, Online
Table 2). The LVEDV was signiﬁcantly lower in the
MypnWT/Q526X mutants compared with WT mice
(p ¼ 0.03). The sphericity index, the ratio of the short-
to long-axis dimensions of the LV, was also lower inthe MypnWT/Q526X mice (0.51  0.03) compared with
WT animals (0.56  0.03; p ¼ 0.02), consistent with
LV remodeling in heterozygotes only.
Arrhythmias and conduction abnormalities are
reportedly present in 15% to 30% of patients with
RCM, especially in pediatric patients (13). Electrocar-
diography revealed that heart rate, pulse, pulse rate,
and QRS durations were similar among mutant and
WT mice, whereas T-wave duration was decreased
in MypnWT/Q526X versus WT or homozygotes (Online
Table 3). Arrhythmias, including premature atrial
contractions, premature ventricular contractions,
and type II second-degree atrioventricular block
(Figure 1C), were observed in heterozygotes only.
FIBROSIS IN HETEROZYGOUS MYPNWT/Q526X HEARTS.
Morphological evaluation of cardiac muscle revealed
no hypertrophy in any animal (Figure 2A). Histologi-
cally, diffuse interstitial and perivascular ﬁbrosis was
found in MypnWT/Q526X ventricular myocardium only.
Dystrophin staining revealed intact sarcolemmal
integrity and normal cardiomyocyte size among
the different groups, conﬁrming absence of car-
diomyocyte hypertrophy (Online Figure 2A). No
positive TUNEL staining was seen in any group,
excluding the involvement of apoptosis. Ultrastruc-
turally, t-tubule enlargement and mild intercalated
disk disruption were seen in heterozygous and
homozygous animals (Figure 2B).
Taken together, these results showed that hetero-
zygote MypnWT/Q526X mutants demonstrated ﬁbrotic
remodeling without an overt hypertrophic response,
accurately recapitulating the human RCM phenotype.
Homozygous MypnQ526X mice had no or a minimal
phenotype as result of MYPNQ526X ablation. There-
fore, further comparative molecular studies were
carried out in MypnWT/Q526X and WT littermates.
PUTATIVE Z-DISK STRESS-SENSOR DYSREGULATION IN
MYPNWT/Q526X HEARTS. Immunohistochemical anal-
ysis revealed no differences in Mypn at the Z-disks.
Notably, coincident delocalization of Carp and
desmin (Des) to the periphery was found in
MypnWT/Q526X cardiomyocytes only (Figure 3, arrows).
On a protein level, although no MypnWT was seen, the
65-kDa MypnQ526X was detected in the hearts of het-
erozygous mice as expected (Figure 4A). A signiﬁcant
increase in the expression of the Mypn homolog, pal-
ladin (90 kDa), was evident inMypnWT/Q526X hearts and
conﬁrmed by monoclonal antibody and immunohis-
tochemical staining (Online Figure 2B). Nebulette and
alpha-actinin were mildly up-regulated, whereas Carp
was considerably down-regulated in MypnWT/Q526X
(p ¼ 0.03). Levels of calpain 3 were similar in mutants
and WT, excluding the likelihood of Carp degradation

































(A) M-mode images of mitral valve (MV) movement by 2-dimensional echocardiography indicate an increase of early and late diastolic
velocities (E/A) ratios in MypnWT/Q526X compared with wild-type (WT) mice or homozygotes, which became signiﬁcant in 12-week-old
heterozygote mutants (blue column) compared with WT and homozygote mice. (B) Cardiac magnetic resonance images in the
4-chamber view demonstrate enlarged left atria in MypnWT/Q526X mice (middle columns) compared with WT (left columns) and MypnQ526X
(right columns) mice. (C) Electrocardiography in WT (a) and mutant (b-d) mice. MypnWT/Q526X mice display arrhythmias (arrows), including
(b) premature atrial contractions, (c) premature ventricular contractions, and secondary atrioventricular block (d; 1:7 Wenkebach).
*p < 0.05. AU ¼ arbitrary units; Mypn ¼ myopalladin.
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FIGURE 2 Morphohistology of Hearts From 12-Week-Old Mice
(A) No signiﬁcant chamber enlargement or cardiac muscle hypertrophy is seen in all groups (upper panels). Sections stained with hematoxylin
and eosin (H&E; 10 magniﬁcation) demonstrate signiﬁcant interstitial and perivascular inﬁltration in the MypnWT/Q526X myocardium (middle
panel), with focal loss of myoﬁbrils (arrow) compared with WT (left panel) and homozygotes (right panel). Masson trichrome staining
(20magniﬁcation) reveals interstitial and perivascular ﬁbrosis in MypnWT/Q526X myocardium. Right lower inset panel displays enlarged details.
(B) Transmission electron microscopy demonstrates no difference in the sarcomeric and Z-disk organization between groups (left panels,
24,000 magniﬁcation). Enlarged t-tubules (arrows) and widened cell-cell junctions with excess convolutions (asterisks) in both mutants are
shown. Other abbreviations as in Figure 1.
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FIGURE 3 Immunohistochemistry of Mouse Hearts
MYPN (red) was coimmunostained with cardiac ankyrin repeat protein (CARP) (A) and desmin (DES) (B), both shown in green. Right panels
represent the merged images with diamidino-2-phenylindole (blue). Although no changes in MYPN localization are noted, the striated
costaining pattern in yellow was lost in MypnWT/Q526X hearts, indicating delocalization of CARP and DES from the cytosol to the periphery of
cardiomyocytes (arrows). Other abbreviations as in Figure 1.
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FIGURE 4 Protein Analysis of Mouse Hearts
(A and B) Western blotting images of WT (left lanes) and MypnWT/Q526X (right lanes) hearts. Signiﬁcant changes in protein expression from
WT were indicated in fold changes in relative density. Expression of 65-kDa MypnQ526X peptide is indicated by the arrow. Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was used as a reference protein. (C) Hypothetical pathogenic mechanisms of diastolic dysfunction caused
by the heterozygous Mypn-Q526X mutation. The left panel depicts an idealized model of normal diastolic function. MYPN-CARP at the “central
I-band” mechano-transmits the titin-PEVK–based myoﬁbrillar stress/strain signals to the nucleus. MYPN connects with NEBL-SH3 and alpha-
actinin (ACTN2), further interacting with actin, gamma-ﬁlamin, and titin-Z-repeats, which are dependent on ERK2 phosphorylation. In
MypnWT/Q526X mice (right panel), levels of mechanosensory molecules are perturbed. CARP and MEK1/2–ERK1/2 levels are reduced; MLP and
DES are up-regulated. CARP-dependent genes such as natriuretic peptide A (NPPA), NPPB, and myosin heavy chain (MYH) are up-regulated,
whereas ERK1/2 downstream genes SMAD1/2 and AKT are down-regulated. *p < 0.05. **p < 0.01. CALP3 ¼ calpain 3; ERK ¼ extracellular
signal–regulated kinase; Mab ¼ monoclonal antibody; MEK ¼ mitogen-activated protein kinase/ERK kinase; MLP ¼ muscle LIM protein;
NEBL ¼ nebulette; PALLD ¼ palladin; SH3 ¼ SRC homology 3; other abbreviations as in Figures 1 and 3.
J A C C V O L . 6 4 , N O . 2 5 , 2 0 1 4 Huby et al.
D E C E M B E R 3 0 , 2 0 1 4 : 2 7 6 5 – 7 6 Z-Disk in Restrictive Cardiomyopathy
2771
Huby et al. J A C C V O L . 6 4 , N O . 2 5 , 2 0 1 4
Z-Disk in Restrictive Cardiomyopathy D E C E M B E R 3 0 , 2 0 1 4 : 2 7 6 5 – 7 6
2772due to increased protease activation. Des and muscle
LIM protein (Mlp/cysteine-rich protein 3 [Csrp3]), the
putative Z-disk stress-sensors, were signiﬁcantly
up-regulated in heterozygotes versus WT (p < 0.05).
Mild down-regulation of alpha-tubulin, caveolin 3,
and vinculin occurred in MypnWT/Q526X compared with
WT, suggesting early recruitment of t-tubules and
adherens junctions, respectively (Online Figure 2B).
Intercalated disk proteins such as desmoplakin 2,
connexin 43, or N-cadherin were not affected. Levels
of cardiac troponin I (cTnI) and phospho-cTnI were
normal, consistent with those of intact sarcomeres.
ANALYSIS OF DOWNSTREAM SIGNALING PATHWAYS.
Because cardiac stretch is regulated mainly at the
Z-disks by extracellular signal–regulated kinase 2
(ERK2)–dependent phosphorylation of titin at the
Zis1/Z-repeats (14), we sought to determine whether
the ERK cascade is altered. Reduced levels of
phosphorylated–mitogen-activated protein kinase
(MAPK)/ERK1/2 (pMek1/2) and pErk1/2 were seen in
MypnWT/Q526X hearts compared with those of WT
(Figure 4B), whereas other potential MAPK-associated
targets, including p53, c-Jun N-terminal kinase, p38,
focal adhesion kinase, nuclear factor kappa–light
chain enhancer of activated B cells, signal transducer
and activator of transcription 3, ERBB4, and trans-
forming growth factor (TGF)-b1, were not affected
(Online Figure 2C). However, there was less phos-
phorylation of Smad2 and Akt in MypnWT/Q526X ani-
mals. Further, CARP-dependent genes, including
natriuretic peptide A (Nppa), Nppb, and myosin heavy
chain 6 mRNA (Online Table 4), were more highly
expressed in MypnWT/Q526X hearts, supporting the
idea of diminished inhibitory effects of CARP due to
reduced levels of CARP protein (Figure 4C). Signiﬁ-
cant increases in the expression of ﬁbrotic (a-smooth
muscle actin, Tgfb1, periostin, and osteopontin),
inﬂammatory (vascular cell adhesion protein, inter-
cellular adhesion molecule, and interleukin-1b), and
antiapoptotic (B-cell lymphoma 2) genes were iden-
tiﬁed in MypnWT/Q526X hearts.
PERSISTENCE OF NUCLEAR 65-KDA MYPN PEPTIDE
ASSOCIATED WITH RCM PHENOTYPE. Mouse hearts
from all groups (WT and heterozygote and homozy-
gote mutants) were fractionated and levels of total,
nuclear, and cytoplasmic Mypn, palladin, and Carp
proteins were quantitated to determine whether the
location and expression levels of the proteins were
associated with the RCM phenotype in vivo. Compa-
rable expression of nuclear palladin was documented
in all groups (Figure 5A), excluding the likelihood of
pathological effects of increased palladin levels in the
nucleus. Interestingly, the 65-kDa MypnQ526X peptidewas detected in the nuclear fraction of heterozygote
hearts, but very little was detected in homozygote
hearts, suggesting a potential cause of the RCM
phenotype. A concordant decrease in total Carp levels
was detected in MypnWT/Q526X hearts.
For further clariﬁcation of MYPN-CARP in-
teractions, different combinations of human MYPNWT
and MYPNQ529X cDNAs fused with GFP or mixtures of
both MYPNWT and MYPNQ529X (MYPNWT/Q529X) were
cotransfected with a human CARP-V5 construct in
HEK293 cells and pulled down. As shown in Figure 5B,
the GFP antibody pulled down the 65-kDa MYPNQ529X
as did the 145-kDa MYPNWT in all transfected
cells, except controls and CARP-transfected ones. In
contrast, levels of V5-pulled 40-kDa CARP were
reduced in MYPNQ529X cells compared with those in
MYPNWT. Further, the 40-kDa CARP-V5 was unde-
tectable in MYPNWT/Q529X mixed lysates, presumably
due to greater reduction of CARP expression
compared with mutant MYPNQ529X cells. These
effects support the in vivo data of reduced murine
Carp levels in heterozygous hearts and the idea
that nuclear 65-kDa MypnQ526X may suppress Carp
expression.
Subsequently, levels of Carp, Mlp, and Des mRNA
were evaluated in the myocardial tissues of hetero-
zygote and homozygote mice to further elucidate
whether differential phenotypes were associated with
nuclear MypnQ526X-mediated alteration in transcrip-
tional activities of mechanosensitive molecules. As
shown in Figure 5C, divergent changes in CARPmRNA
levels were detected in MypnWT/Q529X and MypnQ529X
hearts compared with WT controls. Carp transcription
was reduced in MypnWT/Q529X, whereas MypnQ529X
mice presented Carp up-regulation, and this variation
between mutants was statistically signiﬁcant. In
contrast, no signiﬁcant difference in transcription of
Mlp and Des was revealed in any groups.
DISCUSSION
The characteristic features of autosomal dominant
FRCM result in a high-risk disorder with poor clinical
outcomes, including HF, arrhythmias, and SCD (2).
These features include diastolic dysfunction and
restrictive ventricular ﬁlling, with limited ability to
augment cardiac stroke volume due to increased
myocardial stiffness and interstitial ﬁbrosis; how-
ever, a mechanistic etiology remains unclear (4).
MYPN is a sarcomeric protein localized at the Z-disk,
I-band, and nucleus. Expression of the N-terminal
region of MYPN in cardiomyocytes resulted in severe
disruption of the sarcomere (5), whereas N-terminal
mutation MYPN-Y20C reduced CARP-MYPN binding





















































































































































(A) Levels of MYPN and CARP in cytoplasmic and nuclear fractions and whole lysates of
mouse hearts. GAPDH was used as a cytosolic reference and TATA-box binding protein
(TBP) as a nuclear reference protein. The 65-kDa MypnQ526X peptide is detected (arrow)
in the nucleus, and total CARP levels decrease in MypnWT/Q526X hearts. The 65-kDa
MypnQ526X peptide is degraded, whereas levels of nuclear CARP are increased in MypnQ526X
samples. (B) Immunoprecipitation studies in human embryonic kidney 293 cells. The
expressed human proteins were pulled down with anti–green ﬂuorescent protein (GFP) or
anti-V5 antibodies and detected by Western blotting with anti-GFP (upper panel) or
anti-V5 (lower panels). Reduced levels of pulled-down 65-kDa MYPNQ529X compared with
145-kDa MYPNWT protein in MYPNQ529X cells and MYPNWT/Q529X mixtures are indicated by
arrows. Double arrows indicate reduced levels of 40-kDa CARP-V5 in MYPNQ529X cells
compared with MYPNWT cells, suggesting suppressive effects of mutant MYPNQ529X on
CARP levels. Asterisks indicate a failure of anti-V5 in pulling down 40-kDa CARP-V5 in the
MYPNWT/Q529X mixture. (C) mRNA levels of Carp, Mlp/Csrp3, and Des in mouse hearts
expressed in fold changes relative to levels of Gapdh in WT mice. Results were obtained in
triplicate from 4 mice per group. Csrp ¼ cysteine and glycine-rich protein 3; other
abbreviations as in Figures 1, 3, and 4.
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(Central Illustration) via perturbed MYPN nuclear
shuttling and abnormal assembly of terminal Z-disks
within intercalated disks (9). Mutations in MYPN,
therefore, cause diverse cardiomyopathic phenotypes
within a critical “ﬁnal common pathway” (9,15).
The objectives of this study were to uncover the
molecular pathogenetic mechanism(s) and discover
the associated key signaling molecules in MYPN-
Q529X mutation–induced restrictive remodeling
using a knock-in mouse model. We demonstrated that
homozygous MypnQ526X mice displayed no phenotype
due to ablation of the mutant protein. Heterozygous
MypnWT/Q526X mutants, corresponding to a human
heterozygous MYPN-Q529X mutation, recapitulated
the clinical and pathological features of human
FRCM, including diastolic dysfunction with pre-
served systolic function by 12 weeks of age. Intersti-
tial and perivascular ﬁbrosis was seen before overt
cardiac contractile dysfunction, whereas myocyte
hypertrophy, apoptosis, and necrosis were absent.
From these data, we hypothesize that the RCM
phenotype results from persistence of dysfunctional
truncated MypnQ526X protein and consequent multi-
ple pathological “hits.” First, MypnQ526X translocates
to the nucleus, probably perturbing levels of Carp
expression (Central Illustration). Second, MypnQ526X
causes alterations in Mlp/Csrp3 and Des and blunts
the phosphorylation of Mek1/2–Erk1/2, likely via
negative nuclear feedback. Further, activation of
Smad2 and Akt are reduced, likely to compensate for
the mutation-induced “ﬁnal common pathway” of
RCM (15).
Balanced levels of CARP are reported to be essential for
proper adaptive responses to different stresses in striated
muscle (Central Illustration), includingexercise (16), stretch
(17), cytokines (18), hypoxia (19), adrenergic stress (20), and
anthracycline (doxorubicin) toxicity (21). Multiple mecha-
nisms, including 26S proteasome degradation, TGFb-
SMADs, andcaspase3andcalpain3proteases, are reported
to be CARP regulators (22). Ablation of all forms of muscle
ankyrin repeat proteins (MARPs), including CARP, en-
hances myogenic differentiation protein and MLP
expression in skeletal muscle (23). Although ablation of
CARP or MARPs has been shown to not affect cardiac
function similarly to our MypnQ526X homozygotes (24),
cardiac-restricted CARP overexpression results in an inhi-
bition of hypertrophic andﬁbrotic remodeling via reduced
levels of TGFb and ERK1/2 (18). Our previous MypnY20C
transgenic mouse model (Central Illustration) suggested a
crucial role of nuclear WT Mypn by demonstrating the
development of hypertrophic cardiomyopathy in vivo as a
result of perturbed nuclear shuttling of Mypn (9). In the
present MypnWT/Q526X model, the mutant MypnQ526Xtranslocated to the nucleus, reducing the expression of
Carp. Transcription of a key ﬁbrotic molecule, Tgfb1, was
up-regulated, but Tgfb1 protein levels were not changed,
and Smad2was down-regulated, suggesting an alternative
TGFb-SMAD–independent ﬁbrotic pathway. Increased
expression of 90-kDa palladin was shown to induce
a-smoothmuscleactin throughTgfb1 andErk1/2 activation
(25),whereasdecreasedAnkrd2 andMlp/Csrp3 levelswere
reported in forced skeletal muscle inactivity in mice (26).
Therefore, decreased Carp and elevated Mlp/Csrp3 and
CENTRAL ILLUSTRATION Model of MYPN Mutation–Induced Abnormal Response to Physiological and Pathological Stimuli
In this model, themiddle panel represents normal, balanced MYPN interactions that regulate adequate responses to various stresses. In MYPN-Q529X mutation–induced
RCM, the MYPNQ529X peptide (right panel) translocates to the nucleus, decreases CARP expression, and increases MLP and DES expression on the protein level, leading
to ﬁbrosis via up-regulated POSTN and OPN. The hypertrophic response is abolished via reduced expression of ERK1/2, SMADs, and AKT. Limited or loss of adaptive
responses to various stimuli results in the development of RCM. Conventional cardiovascular drugs, including angiotensin-converting enzyme inhibitors, angiotensin II
receptor blockers, and beta-blockers thus have limited effect in patients with RCM. The left panel represents the mechanism of MYPN-Y20C mutation–induced HCM as a
result of reduced binding of CARP to the MYPNY20C peptide and impaired nuclear translocation of MYPN. Subsequent alterations in DES, ACTN2, VINC, DSP, and Cx43
were evident. ACTN2 ¼ alpha-actinin; AngII ¼ angiotensin II; a,b-AR ¼ alpha- and beta-adrenergic receptors; CARP ¼ cardiac ankyrin repeat protein; Cx43 ¼ connexin
43; DES ¼ desmin; Dox ¼ doxorubicin; DSP ¼ desmoplakin; ERK1/2 ¼ extracellular signal–regulated kinase 1/2; HCM ¼ hypertrophic cardiomyopathy; MLP ¼ muscle
LIM protein; MYPN ¼ myopalladin; NEBL ¼ nebulette; OPN ¼ osteopontin; POSTN ¼ periostin; RCM ¼ restrictive cardiomyopathy; TGF ¼ transforming growth factor;
VINC ¼ vinculin.
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osteopontin in our model (17). Moreover, up-regulation of
intercellular adhesion protein, vascular cell adhesion pro-
tein, and interleukin-1b in mutants may contribute to
perivascular ﬁbrosis (27).
We hypothesized that the net result of decreased
Erk1/2, Smads, and Akt signaling may blunt thehypertrophic response in heterozygotes (Figure 5C).
Because Carp has been shown to regulate the Erk2-
dependent titin-PEVK spring force at the I-band, we
assume that reduction in Mek1/2–Erk1/2 phosphory-
lation might have a negative feedback origin through
the nuclear MypnQ526X-induced perturbation of
mechanosensitive proteins, Carp, Mlp, and Des (28).
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Restrictive
myocardial remodeling is responsible for the diastolic ventricular
dysfunction that characterizes FRCM, which carries a poor
prognosis, particularly in affected children. No pharmacological
therapies have been found that clearly improve clinical outcomes
in patients with this disorder, leaving few alternatives to cardiac
transplant.
TRANSLATIONAL OUTLOOK: This study discovered early
molecular markers of restrictive remodeling in a murine model of
FRCM that caused diastolic dysfunction without contractile
impairment. This points the way toward future studies in which
the expression of genes regulating mechanosensory proteins
could be modiﬁed as potential therapeutic targets.
J A C C V O L . 6 4 , N O . 2 5 , 2 0 1 4 Huby et al.
D E C E M B E R 3 0 , 2 0 1 4 : 2 7 6 5 – 7 6 Z-Disk in Restrictive Cardiomyopathy
2775STUDY LIMITATIONS. An assessment of diastolic
dysfunction ideally includes invasive measurements.
This study adopted an integrated approach using
echocardiography and CMR imaging in the same
cohort of mice and provides compatible data compa-
rable to invasive measurements.
CONCLUSIONS
We demonstrated that the 65-kDa MypnQ526X peptide
caused diastolic dysfunction without contractile
impairment via net changes in the mechanosensory
proteins. To date, no pharmacological therapies have
been shown to clearly improve outcomes in patients
with RCM, with heart transplant being the deﬁnitive
treatment option for many, especially in childhood
(29). If our murine ﬁndings mirror the pathological
hallmarks of RCM in humans, it could explain why the
TGFb1 suppressor angiotensin-converting enzyme
inhibitors, beta-blockers, and angiotensin receptor
blockers are ineffective in the treatment of patients
with RCM (3). Further studies on time-dependent
expression changes in CARP, MLP, DES, and ERK1/2
in patients with RCM may provide useful information
for discovering diagnostic and therapeutic targets.
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